文献速递先天性心脏病外科

肾上腺素能受体基因型影响单心室重建试验婴儿术后结局

Adrenergic receptor genotypes influence postoperative outcomes in infants in the Single-Ventricle Reconstruction Trial.
PubMed 文献 · J Thorac Cardiovasc Surg · 2017-06-24

本研究基于单心室重建试验,对351例接受Norwood手术的左心发育不良综合征婴儿进行4个肾上腺素能受体基因单核苷酸多态性分型,评估其与14个月随访期严重不良事件及术后并发症的关联。结果显示ADRA2A_2790CC基因型与较低的无事件生存率独立相关,而术后并发症发生率无基因型差异。

要点

  • ADRA2A_2790CC基因型与Norwood术后14个月无严重不良事件生存率降低独立相关。
  • 术后并发症发生率未因肾上腺素能受体基因型不同而存在差异。
  • 携带与儿茶酚胺释放或敏感性增高相关的基因型者无事件生存率更低。

核心结论

  • 携带与儿茶酚胺释放或敏感性增高相关的ADR基因型的HLHS婴儿,分期姑息术后无事件生存率更低。

研究设计与样本

  • 基于单心室重建试验的前瞻性队列,纳入351例HLHS婴儿,对ADRB1_231A/G、ADRB1_1165G/C、ADRB2_5318C/G和ADRA2A_2790C/T进行基因分型,采用Cox回归和Poisson回归分析。

主要发现

  • 14个月随访期间152例发生严重不良事件,包括84例死亡和10例移植。
  • ADRA2A_2790CC基因型较CT/TT基因型无事件生存率更低(Log rank P = .02),校正临床和手术危险因素后独立相关(校正Cox回归,风险比1.54 [95%CI 1.04, 2.30],P = .033)。
  • Norwood术后并发症发生率未因基因型不同而存在差异。

临床怎么用

  • 对携带ADRA2A_2790CC等高儿茶酚胺活性相关基因型的HLHS婴儿,Norwood术后应加强监测和随访。

局限性

  • 研究为观察性关联分析,不能证明因果关系。
  • 结论基于特定试验人群,外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Adrenergic receptor (ADR) genotypes have been associated with adverse outcomes in heart failure. Our objective was to evaluate the association of ADR genotypes with post-Norwood outcomes in infants with hypoplastic left heart syndrome (HLHS). METHODS: Infants with HLHS participating in the Pediatric Heart Network Single-Ventricle Reconstruction Trial underwent genotyping for 4 single-nucleotide polymorphisms in 3 ADR genes: ADRB1_231A/G, ADRB1_1165G/C, ADRB2_5318C/G, and ADRA2A_2790C/T. The association of genotype with freedom from serious adverse events (SAEs) (death, transplant, extracorporeal membrane oxygenation, cardiopulmonary resuscitation, acute shunt failure, unplanned reoperations, or necrotizing enterocolitis) during 14 months' follow-up was assessed with Cox regression and the association with post-Norwood complications was assessed with Poisson regression. Models were adjusted for clinical and surgical factors. RESULTS: The study included 351 eligible patients (62% male; 83% white). The mean age at Norwood procedure was 5.6 ± 3.6 days. A total of 152 patients had SAEs during 14-month follow-up including 84 deaths and 10 transplants. ADRA2A_2790CC genotype had lower SAE-free survival compared with CT/TT genotypes during follow-up (Log rank test, P = .02), and this association was independent of clinical and surgical risk factors (adjusted Cox regression, hazard ratio 1.54 [95% confidence interval 1.04, 2.30] P = .033). Post-Norwood complication rate did not differ by genotype. CONCLUSIONS: Infants with HLHS harboring ADR genotypes that are associated with greater catecholamine release or sensitivity had lower event-free survival after staged palliation. Excess catecholamine activation may adversely affect cardiovascular adaptation after the Norwood procedure. Future studies should explore whether targeting adrenergic activation in those harboring risk genotypes can improve outcomes. (ClinicalTrials.gov number NCT00115934).

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Ramroop R, Manase G, Lu D, et al. Adrenergic receptor genotypes influence postoperative outcomes in infants in the Single-Ventricle Reconstruction Trial. J Thorac Cardiovasc Surg. 2017. PMID: 28734628. doi:10.1016/j.jtcvs.2017.06.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。